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Hypertension is prevalent in the population at
large and among hospitalized patients. Little has
been reported regarding the attitudes and patterns
of care of physicians managing nonemergent
elevated blood pressure (BP) among inpatients.
Resident physicians in internal medicine (IM),
family medicine (FM), and surgery were surveyed
regarding inpatient BP management. One
hundred eighty-one questionnaires were
completed across 3 sites. Respondents generally
considered inpatient BP control a high priority.
A majority of IM and FM residents indicated
following the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure (JNC 7)
consensus guidelines for inpatients compared to
20% of surgery residents (P<.001). While trainees
did not appear to strictly follow JNC 7 guidelines
for goal BP of 140 ⁄ 90 mm Hg, they did report
making frequent BP medication changes (51%
reported changing regimens for >50% of
hypertensive patients). Overall 90% indicated
that discharging a hypertensive patient on a drug
regimen established during hospitalization is
preferable to reverting to the regimen in place at
the time of admission. Resident physicians regard
elevated BP inpatient management as important,
but attitudes and practice vary between specialties.
JNC 7 guidelines may not be appropriate for
inpatient use. Future research should focus on
developing functional diagnostic criteria for
hypertension in the inpatient setting and
determining best practices inpatient BP
management. J Clin Hypertens (Greenwich).
2010;12:698–705. ª2010 Wiley Periodicals, Inc.
While guidelines for hypertension manage-ment and studies of control efforts over the
past 30 years have fittingly concentrated on the
outpatient setting, evidence suggests that the
prevalence of hypertension in the inpatient setting
is as high as 50%.1 Hospitalization is common in
the United States. In 2002, there were more than
38 million inpatient hospitalizations and roughly
33 million additional surgical procedures among
adults.2,3 Available studies indicate that recogni-
tion and control of hypertension in the inpatient
setting are suboptimal, even in patients with
high-risk conditions such as ischemic heart dis-
ease and stroke.4–10 Thus, the inpatient setting
might reasonably be a site to focus efforts to
improve hypertension treatment.
While experts generally agree on principles for
treatment of the range of hypertensive emergency
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syndromes,11–13 there is no consensus recommenda-
tion regarding the management of nonemergent or
asymptomatic elevated blood pressure (BP) in the
inpatient setting. The Seventh Report of the Joint
National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure
(JNC 7) does not specifically address inpatient
hypertension, and the utility of these guidelines in
the hospital setting is not established.14 In fact, very
little published information is available about the
knowledge and practices of inpatient physicians in
the management of elevated BP.
In the present study, we have attempted to
describe the approach of medical trainees in inter-
nal medicine (IM), family medicine (FM), and sur-
gery regarding elevated BP in the inpatient setting.
Survey questions focused on 2 primary dimensions
of care: the general diagnosis and management of
inpatient BP, and care transitions for inpatients
with elevated BP.
MATERIALS AND METHODS
Study Design, Setting, and Participants
We conducted a cross-sectional survey of resident
physicians in IM, FM, and surgery training pro-
grams at 3 sites: The University of Michigan, The
Medical University of South Carolina, and the
Spartanburg (South Carolina) Regional Medical
Center. The former 2 sites are university-based
medical centers, and the latter is a community-
based hospital hosting training programs in FM
and preliminary surgery. Trainees were approached
by study personnel and invited to complete ques-
tionnaires in either pen ⁄paper format or using an
online survey form (http://www.surveymonkey.
com). Survey items varied slightly by site and com-
plete surveys are available in Supporting Informa-
tion. Common survey items are presented in this
report. Questionnaire items were varied in structure
including rating scales, checklists, and case vignettes
(these were administered only at the South Carolina
sites). Surveys were reviewed and approved by insti-
tutional review boards at each site. All survey
responses were anonymous. Of note, respondents
at the Medical University of South Carolina were
provided with coupons valued at $5.00 for bever-
ages at an in-hospital coffee kiosk independent of
their decision to complete survey forms.
Statistical Analysis
Upon completion, survey results from each site
were combined and tabulated. The primary group
comparisons were made based on training program
(IM, FM, and surgery). Survey responses were
dichotomized and between-group differences were
tested using chi-square or Fisher exact tests as
appropriate. All analyses were performed using SAS
statistical software package version 9.1 (SAS Insti-
tute Inc, Cary, NC).
RESULTS
Demographic characteristics of survey respondents
are shown in Table I below. Approximately two-
thirds of trainee respondents were from IM, 18%
from FM, and 17% from surgical specialties (gen-
eral surgery, orthopedic surgery, and preliminary
surgery). In general, respondents were evenly dis-
tributed based on sex and the number of years in
training. IM residents self-reported a median of 7
to 8 inpatient months in the past 12 months,
and FM resident’s self-reported a median of 3 to
4 months.
Survey questions and responses dealing with the
management of elevated BP among inpatients sepa-
rated by specialty are listed in Table II below.
Overall, 80% rated control of BP as 4 or 5 out of
5 in importance (5 = very important). As indicated
in Figure 1 and Figure 2, there were no significant
differences between specialties regarding the impor-
tance attributed to inpatient BP control, frequency
of manually rechecking BP, correlation of elevated
BP with medication timing, and frequency of chang-
ing BP medications. Similarly, a majority of respon-
dents reported that they based their management
on current JNC 7 guidelines. However, there was a
notable difference between specialty training groups
on this question (Figure 2). Ninety-seven percent of
FM, and 70% of IM residents acknowledged use
of these guidelines, but only 19% of surgery resi-
dents did so (P<.001). In separate questions about
the level of BP that would spur a medication
change in a hospitalized patient, no group was
likely to institute a BP medication change at
<140 ⁄90 mm Hg. However, the threshold for med-
ication changes was higher for surgical residents
than IM or FM residents (Figure 2). At a systolic
BP 160 mm Hg, 63% of FM residents and 57%
of IM residents would institute a medication
change, but only 29% of surgical residents would
do so (P<.001). Similarly, at a diastolic BP
100 mm Hg 65% of FM and 64% of IM resi-
dents would implement a medication change, but
only 23% of surgical residents would do so
(P<.001). In case vignettes, respondents were
divided on how they chose to deal with an asymp-
tomatic, moderately elevated BP observed in an
inpatient. Overall, 44% indicated that they would
treat with either an oral or intravenous agent, and
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56% indicated that they would not treat the
hypothetical patient with antihypertensive medica-
tion. Regarding the use of hypertension specialists
(Figure 2) 59% of FM and IM residents indicated
that they would not consult a hypertension special-
ist, but only 14% of surgeons stated they would
not do so (P<.001).
Survey questions and responses dealing with care
transitions for patients with elevated inpatient BP
are listed by specialty in Table III below. Overall,
91% of respondents agreed that the final antihyper-
tensive medication regimen arrived at during hospi-
talization should be the regimen at discharge, and
there was no significant variation between IM and
FM residents on this point. Also, 71% of respon-
dents indicated that an appropriate follow-up inter-
val for uncontrolled inpatient BP should be 1 to
2 weeks after discharge. IM trainees (16% of total)
were more comfortable with longer follow-up inter-
vals of greater than 2 weeks. In case vignettes,
66% of respondents claimed they would take mul-
tiple steps to document and treat BP including pre-
scribing a new medication at discharge in a patient
with newly diagnosed hypertension. However, only
7.8% surveyed would contact a primary care pro-
vider for input in titrating medications on a com-
plex heart failure patient with uncontrolled BP.
Table IV lists the preferred oral and intravenous
antihypertensive medications indicated by trainees.
In general, b-blockers (84.5%), angiotensin-convert-
ing enzyme inhibitor ⁄angiotensin receptor antago-
nists (70.7%), calcium channel blockers (56.9%),
and diuretics (55.8%) were most favored for oral
treatment of elevated BP among hospitalized
patients. Interestingly, hydralazine was preferred by
50.8% of respondents overall, largely driven by IM
and surgical trainees. b-Blockers (61.9%) and
hydralazine (76.2%) were the most preferred par-
enteral agents.
DISCUSSION
To our knowledge, this is the first report of resident
physicians’ attitudes and practices in the manage-
ment of elevated BP in the inpatient setting. Survey
respondents generally agreed that the management
of inpatient hypertension was a high priority, and a
majority indicated that they use current expert
guidelines as a framework for delivering care, even
though those guidelines do not specifically address
the diagnosis and management of hypertension in
the inpatient setting. However, respondents’
answers to survey items indicate that they do not in
fact use the standard JNC 7 outpatient treatment
recommendations. A majority reported that patients










Female 24 10 NAb
Male 45 12 NAb
Years in training
1 20 10 21 51 (28%)
2 23 7 28 58 (32%)
3 18 5 24 47 (26%)
3 or more 7 0 17 24 (14%)
Inpatient monthsa
1–2 3 5 NAb
3–4 10 12 NAb
5–6 17 5 NAb
7–8 25 0 NAb
9–10 13 0 NAb
11–12 1 0 NAb
Specialty
Internal medicine 69 0 50 119 (66%)
Family medicine 0 20 11 31 (18%)
Orthopedic surgery 0 0 20 20 (11%)
General surgery 0 0 9 9 (5%)
Transitional 0 2 0 2 (1%)
aSelf-reported number of months spent on primarily inpatient rotations in the previous year. bInformation on sex and number
of inpatient months was not collected in the Michigan version of the survey.
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Controlling BP in the hospital is:
(Not important) 1 0 (0) 0 (0) 0 (0) 0 (0)
2 5 (4.2) 1 (3.2) 2 (6.5) 8 (4.5)
3 23 (19.3) 3 (9.7) 3 (9.7) 29 (16.0)
4 53 (44.5) 15 (48.4) 18 (58.0) 86 (47.5)
(Very important) 5 38 (31.9) 12 (38.7) 8 (25.8) 58 (32.0)
I routinely retake the BPs myself in my hospitalized patients.
(Never) 1 20 (16.8) 13 (43.3) 6 (19.4) 39 (21.7)
2 61 (51.3) 13 (43.3) 17 (54.8) 91 (50.6)
3 28 (23.5) 4 (13.4) 6 (19.4) 38 (21.1)
4 9 (7.6) 0 (0) 2 (6.4) 11 (6.1)
(All patients) 5 1 (0.8) 0 (0) 0 (0) 1 (0.5)
In evaluating BP, I routinely relate the timing of BP measurements to the time medications are given to my patients.
(Never) 1 0 (0) 3 (10.0) 0 (0) 3 (1.8)
2 15 (13.6) 4 (13.3) 3 (11.5) 22 (13.2)
3 31 (28.2) 9 (30.0) 10 (38.5) 50 (30.1)
4 53 (48.2) 13 (43.3) 13 (50.0) 79 (47.6)
(All patients) 5 11 (10.0) 1 (3.4) 0 (0) 12 (7.3)
In what percentage of patients on your service do you adjust medications to reduce their BP while the patient is in the hospital?
<20% 14 (11.8) 2 (6.5) 4 (12.9) 20 (11.0)
20%–50% 45 (37.8) 10 (32.2) 14 (45.2) 69 (38.1)
50%–80% 44 (37.0) 11 (35.5) 7 (22.6) 62 (34.3)
>80% 16 (13.4) 8 (25.8) 6 (19.3) 30 (16.6)
At what level of BP do you initiate medication changes while the patient is in the hospital? (mean, standard deviation)
Systolic BP (mm Hg)
140–149 34 (28.6) 11 (35.5) 2 (6.5) 47 (26.0)
150–159 20 (16.8) 6 (19.4) 6 (19.3) 32 (17.7)
160–169 21 (17.7) 8 (25.8) 14 (45.2) 43 (23.7)
170–179 13 (10.9) 1 (3.2) 5 (16.1) 19 (10.5)
180+ 6 (5.0) 1 (3.2) 1 (3.2) 8 (4.4)
No specific number (% of respondents) 25 (21.0) 4 (12.9) 3 (9.7) 32 (17.7)
Diastolic BP (mm Hg)
90–99 54 (45.4) 17 (54.8) 6 (19.4) 77 (42.5)
100–104 16 (13.5) 7 (22.6) 15 (48.4) 38 (21.0)
105–109 13 (10.9) 1 (3.2) 2 (6.5) 16 (8.8)
110–114 1 (0.8) 1 (3.2) 2 (6.5) 4 (2.2)
115+ 0 (0) 0 (0) 1 (3.2) 1 (0.6)
No specific number (% of respondents) 35 (29.4) 5 (16.1) 5 (16.1) 45 (24.9)
I base my decisions regarding medications to reduce BP on the Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guideline recommendations.
Yes 83 (69.8) 30 (96.8) 6 (19.3) 119 (65.8)
No 36 (30.2) 1 (3.2) 25 (80.7) 62 (34.2)
I would consult a hypertension specialist:
I would not call a hypertension specialist 68 (59.1) 10 (58.8) 4 (13.8) 82 (51.0)
After adjusting the dose of 1 current
medication if inadequate response
0 (0) 1 (5.9) 1 (3.4) 2 (1.2)
After adjusting the dose of 2 current
medications if inadequate response
29 (25.2) 4 (23.5) 14 (48.3) 47 (29.2)
After adding on one additional
anti-hypertensive medication
13 (11.3) 2 (11.8) 6 (20.7) 21 (13.0)
If a patient’s BP was over ___ ⁄ ___.
(mean, SD, number responding)
5 (4.4) 0 (0) 4 (13.8) 9 (5.6)
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would need to have BP in excess of 160 ⁄100 mm
Hg prior to instigating medication changes rather
than the 140 ⁄90 mm Hg threshold outlined in JNC
7. Still, 51% stated that they frequently adjust anti-
hypertensive regimens in hospitalized hypertensives.
The efficacy and safety of such frequent changes in
antihypertensive medications among stable inpa-
tients is unclear.
There is also ambiguity regarding proper man-
agement of transiently elevated BP in the inpatient
setting. In a case scenario, 44% of respondents
indicated that they would treat acutely elevated BP
in an asymptomatic patient. There is no evidence
of benefit for administering antihypertensives in this
setting, and the potential certainly exists for harm.
One rationale for pharmacologic treatment of
acutely elevated BP involves the concept of ‘‘trigger-
ing’’ whereby certain stressors acutely precipitate
adverse cardiovascular events. Triggering of myo-
cardial infarction has been causally linked to emo-
tional upset, strenuous physical activity, lack of
sleep, and overeating.15 However, the question of
whether acute, asymptomatic elevations in BP can
precipitate adverse cardiovascular events among in-
patients has never been formally studied. There is
also an association between early morning surge in
BP and a higher incidence of heart attacks and
stroke in the early morning hours, but it is unclear
whether this phenomenon is exaggerated in the
inpatient setting.
A stronger case can be made that inpatient hospi-
talization represents an opportunity to recognize
uncontrolled hypertension and improve postdis-
charge care transitions instead of intervening during
the inpatient hospitalization. For patients with
known, but uncontrolled hypertension, such recog-
nition allows inpatient providers to alert outpatient
treating physicians that there may be a problem with
BP control. For patients without known hyperten-
sion, such recognition offers the chance to refer for
treatment and to begin therapy in selected cases.
However, diagnostic uncertainty impairs inpa-
tient physicians’ ability to make decisions about











How soon after discharge should patients in whom BP has required initiation or adjustment of drugs while in the hospital be
seen?
<1 week 15 (12.6) 10 (32.3) 10 (32.3) 35 (19.3)
1–2 weeks 85 (71.4) 20 (64.5) 21 (67.7) 126 (69.6)
3–4 weeks 16 (13.5) 1 (3.2) 0 (0) 17 (9.4)
>4 weeks 3 (2.5) 0 (0) 0 (0) 3 (1.7)
In general, for patients treated for hypertension prior to hospitalization, should they be discharged on:
The final drug regimen established
during the hospitalization
106 (91.4) 29 (93.6) 27 (87.1) 162 (91.0)
The drug regimen on which they
were admitted
10 (8.6) 2 (6.4) 4 (12.9) 16 (9.0)
Figure 1. Between-group differences for selected survey
items.
Figure 2. Between-group differences for selected survey
items.
THE JOURNAL OF CLINICAL HYPERTENSION VOL. 12 NO. 9 SEPTEMBER 2010702
medication regimens at the time of discharge. Mea-
surement techniques and diagnostic standards for
outpatient hypertension are well established,16 but
numerous factors complicate hypertension diagnosis
in the inpatient setting. Inpatients are a heteroge-
neous group with a variety of different primary
inpatient diagnoses and medical comorbidities, as
well as clinical factors such as acute illness, pain,
nausea, and medication changes. Also, measure-
ment of inpatient BP is often imprecise because of
the use of poorly calibrated oscillometric devices
and from lapses in proper measurement technique
such as incorrect cuff size and lack of attention to
the effects of posture and arm position. This is rele-
vant given that 81% of respondents indicated that
they never or rarely ever recheck BP themselves in
hospitalized patients (Table II).
Discontinuity between the inpatient and outpa-
tient settings represents another significant barrier.
The proliferation of hospitalist physicians in the
United States and several other factors have led to
poorer continuity of care in recent decades,17 espe-
cially because communication between inpatient
physicians and primary care physicians can be
poor. In one study, only 14.5% of discharge
summaries arrived at patients’ primary care physi-
cians within 1 week of hospital discharge, and
25% never arrived.18 Discontinuity has the dual
effect of making appropriate medication changes
less likely to persist and of introducing potential for
adverse medication events. Such events after hospi-
tal discharge are common19,20 and may be avoid-
able with improved communication and care
coordination.21–23





You are called by a nurse at 10 pm with an elevated BP of 182 ⁄ 100 mm Hg in a 74-y-old female with known HTN on her
home medications who is not in any pain and has no other symptoms other than the cough caused by her pneumonia. How
would you respond?
Give 20 mg IV labetalol and recheck BP in 1 h. 10 (14.7) 1 (5.0) 0 (0) 11 (12.2)
Give 0.2 mg of oral clonidine and recheck BP in 1 h. 1 (1.5) 0 (0) 0 (0) 1 (1.1)
Do nothing acutely. 17 (25.0) 2 (10.0) 0 (0) 19 (21.1)
Give codeine for her cough. 40 (58.8) 17 (85.0) 2 (100.0) 59 (65.6)
Your 32-y-old male patient who was involved in a motor vehicle collision is being discharged today. You notice that he has had
persistently, but mildly elevated BPs (140–159 ⁄ 90–100 mm Hg) over the past 3 days prior to discharge that are not clearly rela-
ted to pain or nausea. He has no primary care physician, and he takes no medications for HTN at home. His kidney function
was normal on admission, but he does have trace proteinuria on urinalysis, and ECG showed left ventricular hypertrophy. What
actions are you likely to take in response to this elevated BP?
1. No response is necessary. We are not sure these
elevated BP measures represent true HTN.
11 (16.4) 7 (35.0) 0 (0) 18 (20.2)
2. Tell the patient he has stage 1 HTN and note this in
his discharge summary.
17 (25.4) 4 (20.0) 0 (0) 21 (23.6)
3. # 2 above, and tell him to get primary care follow up. 27 (40.3) 5 (25.0) 2 (100) 34 (38.2)
4. # 3 above, and prescribe a medication for HTN. 12 (17.9) 4 (20.0) 0 (0) 16 (18.0)
You have a 65-y-old patient with known HTN, hyperlipidemia, and revascularized coronary artery disease, compensated ische-
mic cardiomyopathy with an ejection fraction of 30% who is seen after an elective procedure. During the 3 days of hospitaliza-
tion, systolic BP has ranged from 150 to 170 mm Hg based on nurses’ oscillometric BP measures. Current HTN medications
include metoprolol tartrate 25 mg twice a day, lisinopril 40 mg ⁄ d, and furosemide 40 mg ⁄ d. She is followed for primary care
by a family medicine physician in a neighboring town. Which of the following describes what you are most likely to have done
if faced with a similar patient in the past year?
Continue home medications as the patient is
compensated and has good follow-up care.
6 (8.8) 3 (15.0) 1 (50.0) 10 (11.1)
Switch to metoprolol succinate at a titrated dose
that has better ‘‘data’’ for use in patients with heart failure.
25 (36.8) 7 (35.0) 0 (0) 32 (35.6)
Add spironolactone 25 mg daily to the patient’s regimen. 32 (47.1) 8 (40.0) 1 (50.0) 41 (45.5)
Call the primary care physician and ask what they
suggest doing.
5 (7.3) 2 (10.0) 0 (0) 7 (7.8)
Abbreviations: BP, blood pressure; ECG, electrocardiogram; HTN, hypertension; IV, intravenous. aClinical vignette items were
completed at the Medical University of South Carolina and Spartanburg sites only.
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The strong preference of trainees for hydralazine
for hypertensive urgency in non–intensive-care-unit
patients is curious given that there do not appear
to be any randomized controlled clinical trials with
this medication for this indication. However, sepa-
rate data on the prescribing of hydralazine at the
University of Michigan support the notion that
hydralazine usage is common, concordant with resi-
dents’ self-reported preferences.24 Several recent
review articles on the subject of hypertensive
urgency ⁄emergency discuss the use of hydralazine
in this context.11,12,25 Two authors suggest that this
be restricted to use only in preecclampsia ⁄ecclamp-
sia,11,12 and the third states that hydralazine should
be relatively contraindicated in hypertensive crisis.25
It is possible that the medication choices in the
non–intensive-care-unit setting are driven by other
factors such as nursing-unit–specific restrictions on
the use of intravenous antihypertensives rather than
clinical trials or expert guidelines.
This study should be interpreted in light of its
limitations. This survey study is comprised of a
convenience sample of resident physicians, and
results may not describe the knowledge and prac-
tices of all trainees. The study is strengthened, how-
ever, by featuring multiple sites spanning 2
geographic regions, by including both university-
based and community-based training programs,
and by the inclusion of multiple specialties. Simi-
larly, the knowledge and practices of attending phy-
sicians responsible for final disposition in each
specialty may not mirror those of trainees. It is fur-
ther possible that survey results were biased
because respondents were invited by their attending
physicians to participate. This seems unlikely,
though, as the survey was anonymous, largely
online, and because gifts (offered only at one site)
were of nominal value ($5.00) and not tied to par-
ticipation. Finally and importantly, this survey
relied on self-reported practices, and actual practice
patterns may vary.
In closing, the present study provides new insight
into the practice patterns of resident physicians in
treating elevated BP in the inpatient setting.
Respondents generally rated inpatient hypertension
as a high priority, and they reported being fairly
aggressive in titrating medications and treating
acutely elevated, asymptomatic BP, but there were
discrepancies between self-reported practices and
expert guidelines. Also, there was significant varia-
tion in management between specialties. Future
research in this area should focus on the develop-
ment of functional diagnostic criteria for hyperten-
sion in the inpatient setting, determining what are
the best practices for the management of nonemer-
gent, elevated BP in the inpatient setting, minimiz-
ing training-specific variations in care that could
affect patient outcomes, documenting the overall





Medicine (%) Surgery (%) Total (%)
Oral agents
ACE inhibitors ⁄ ARB 73.1 80.6 51.6 70.7
a-Blockers 6.7 22.6 12.9 10.5
a-b-Blockers 14.3 22.6 25.8 17.7
b-Blockers 80.7 90.3 93.5 84.5
Calcium channel blockers 54.6 74.2 48.4 56.9
Clonidine 16.8 25.8 35.5 21.5
Diuretics 54.6 64.5 51.6 55.8
Hydralazine 56.3 35.5 45.2 50.8
Other 4.2 3.2 0 3.3
Intravenous agents
ACE inhibitors ⁄ ARB 5 12.9 6.5 6.6
a-b-Blockers 9.2 22.6 25.8 14.4
b-Blockers 55.5 77.4 71 61.9
Calcium channel blockers 15.1 25.8 32.3 19.9
Diuretics 13.4 16.1 35.5 17.7
Hydralazine 84 45.2 77.4 76.2
Other 3.4 0 9.7 3.9
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker. aRespondents were allowed to select any
oral or intravenous drug class ⁄ agent listed without limits on the number to be selected. Thus, percentages may total >100%.
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risk associated with acute, asymptomatic elevations
of BP as a possible trigger for adverse clinical
events, and on best practices for care transitions in
patients with sustained elevations of BP observed in
the inpatient setting.
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